Filters

Anti-ARL8B (Polyclonal), ALEXA Fluor 594

Anti-ARL8B (Polyclonal), ALEXA Fluor 594 size: 100 microliters 489

Supplier BIOSS POLYCLONAL ANTIBODIES
Price 489
Size 100 microliters
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
TypeConjugated Primary Antibody
Conjugated with 594, ALEXA FLUOR®
Host organismRabbit (Oryctolagus cuniculus)
Target Protein/PeptideARL8B
SpecificityThis antibody reacts specifically with ARL8B
ModificationNo modification has been applied to this antibody
Modification siteNone
ClonalityPolyclonal Antibody
ClonePolyclonal Antibodies
Concentration1ug per 1ul
Subcellular locationsN/A
Antigen SourceKLH conjugated synthetic peptide derived from human ARL8B
Gene ID55207
Swiss ProtN/A
ApplicationsIF(IHC-P)
Applications with corresponding dilutionsIF(IHC-P)(1:50-200)
Cross reactive species Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens)
Cross Reactive Species details However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species, No significant cross reactivity has been observed for this antibody for the tested species
Background information ARFâ, ARL8A interacts with Tubulin and is thought to play a role in lysosome motility, ARL8B (ADP-ribosylation factor-like protein 8B), Expressed ubiquitously, The gene encoding ARL8B maps to human chromosome 3, also known as ARL10C or GIE1, as well as in chromosomal segregation, including a chemokine receptor (CKR) gene cluster and a variety of human cancer-related gene loci, is a 186 amino acid protein that localizes to the late endosome membrane and belongs to the ARL family of ARF-like GTPase proteins, which houses over 1, &euro, &trade, 100 genes, ADP-ribosylation factors (ARFs) are highly conserved guanine nucleotide binding proteins that enhance the ADP-ribosyltransferase activity of Cholera Toxin, s are important in eukaryotic vesicular trafficking pathways and they play an essential role in the activation of phospholipase D (PC-PLD)
Purification methodPurified by Protein A
Storage 50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA
Excitation emission590nm/617nm
Synonyms FLJ10702 Gie1
Also known asARL8B Polyclonal Antibody
Other nameAnti-ARL8B Polyclonal
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody
PropertiesFor facs or microscopy Alexa 1 conjugate
ConjugationAlexa Fluor
GroupPolyclonals and antibodies
About The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot
Gene targetARL8B
Short nameAnti-ARL8B (Polyclonal) Fluor 594
Technique Pabs are a collection of immunoglobulin , Polyclonal antibodies , each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different 
LabelALEXA
Alternative name ALEXA Fluor 594, antibody to-ARL8B (polyclonal)
Alternative techniquepolyclonals
Identity 25564
Gene ARL8B
Long gene name ADP ribosylation factor like GTPase 8B
Synonyms gene ARL10C
Synonyms gene name ADP-ribosylation factor-like 10C ADP-ribosylation factor-like 8B
Locus 3p26, 1
Discovery year 2004-02-05
GenBank acession AK001564
Entrez gene record 55207
Pubmed identfication 12477932 24088571
RefSeq identity NM_018184
Classification ARF GTPase family
Havana BLAST/BLAT OTTHUMG00000090463

Similar products

Subscribe to our Newsletter